why choose us

First received: August 30, 2023

Clinical Trial: Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alzheimer Disease

Study Type: OBSERVATIONAL


Official Title: Quality Improvement PrecivityAD2(TM): A Survey and Clinical Utility Study of the PrecivityAD2 Blood Test in the Evaluation of Cognitive Impairment (QUIP II)

Brief Summary: There is a major unmet need for timely, non-invasive, and low-burden evaluation of patients presenting with mild cognitive impairment (MCI) and dementia.MCI impacts 12-18% of people in the United States over age 60 years (Alzheimer's Association.Mild Cognitive Impairment (MCI) available at https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment.Accessed August 16, 2022).MCI does not substantially interfere with daily activities,…

Read more